Corporate News     19-Jul-24
Zydus' transdermal manufacturing site completes USFDA inspection
Zydus Lifesciences announced that the USFDA conducted an inspection at the group's transdermal manufacturing site located at SEZ in Ahmedabad. The inspection was conducted from 15 July to 19 July 2024.

The inspection closed with 2 observations. The Company is confident of addressing the issues raised by the USFDA within the stipulated timeline, and is committed to resolving the same at the earliest.

Previous News
  Nifty slips below 25,850 mark; realty shares witness profit booking
 ( Market Commentary - Mid-Session 12-Feb-26   11:33 )
  Zydus Lifesciences gains on settlement with Astellas over Myrbetriq
 ( Hot Pursuit - 12-Feb-26   10:49 )
  Zydus update on settlement agreement with Astellas
 ( Corporate News - 12-Feb-26   09:13 )
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 10-Feb-26   11:38 )
  Zydus Lifesciences
 ( Results - Analysis 09-Feb-26   15:39 )
  Zydus Lifesciences consolidated net profit rises 1.82% in the December 2025 quarter
 ( Results - Announcements 09-Feb-26   16:59 )
  Zydus receives USFDA Orphan drug designation for Desidustat
 ( Corporate News - 06-Feb-26   12:45 )
  Zydus receives USFDA tentative approval for Dapagliflozin Tablets
 ( Corporate News - 04-Feb-26   16:07 )
  Zydus Lifesciences to discuss results
 ( Corporate News - 28-Jan-26   10:46 )
  Zydus Lifesciences' Ankleshwar unit completes USFDA inspection
 ( Corporate News - 24-Jan-26   10:51 )
  Zydus Lifesciences launches world's first biosimilar of Nivolumab in India
 ( Corporate News - 22-Jan-26   12:54 )
Other Stories
  Hindustan Unilever completes acquisition of 49% stake in Zywie Ventures
  13-Feb-26   18:55
  Lupin allots 75,273 equity shares under ESOP
  13-Feb-26   18:53
  Marico allots 10,356 equity shares under ESOP
  13-Feb-26   18:52
  United Spirits announces change in Chief HR Officer
  13-Feb-26   18:48
  Shriram Finance receives credit ratings from CARE
  13-Feb-26   18:47
  Board of CRISIL recommends Final Dividend
  13-Feb-26   17:50
  Board of The Bombay Burmah Trading Corp. recommends Interim Dividend
  13-Feb-26   17:49
  Board of Taneja Aerospace & Aviation recommends First Interim Dividend
  13-Feb-26   17:49
  Take Solutions EGM scheduled
  13-Feb-26   17:41
  Board of Torrent Pharmaceuticals recommends interim dividend
  13-Feb-26   17:37
Back Top